Key result
A systolic inter-arm blood pressure difference of ≥5 mmHg was associated with increased odds of substantial cognitive decline over a median 9-year follow-up (OR 1.46).
Why the study?
Systolic inter-arm difference in blood pressure (IAD) and cognitive decline are both associated with cardiovascular disease, leading to the hypothesis that IAD may predict cognitive decline.
Does a systolic inter-arm blood pressure difference ≥5 mmHg predict cognitive decline in older adults?
Cohort (n=1,133)
Does a systolic inter-arm blood pressure difference ≥5 mmHg predict cognitive decline in older adults?
A systolic inter-arm blood pressure difference of ≥5 mmHg is associated with an increased risk of cognitive decline in older adults, suggesting it could serve as an early clinical marker for targeted prevention.
Answers are grounded in this paper and cite their sources.
May flag higher cognitive decline risk in older adults; leaves open whether IAD improves risk stratification.
BACKGROUND: Systolic inter-arm difference in blood pressure (IAD) and cognitive decline are both associated with cardiovascular disease; therefore, it was hypothesised that IAD may be predictive of cognitive decline. AIM: To examine associations of IAD with cognitive decline in a community population. DESIGN AND SETTING: A prospective study of older Italian adults enrolled in the InCHIANTI study. METHOD: Univariable and multivariable associations of IAD were explored with declines in mini mental state examination (MMSE) scores, Trail Making Test A and B scores, and a composite outcome representing substantial decline in any of these scores. Backward stepwise regression was used to adjust observed associations of IAD with cognitive decline. RESULTS: The rate of decline for MMSE scores in 1133 participants was greater with IAD ≥5 mmHg or ≥10 mmHg. On univariable analyses continuous IAD was associated with the composite outcome (odds ratio [OR] 1.16 per 5 mmHg of IAD, 95% confidence interval [CI] = 1.02 to 1.31). Substantial decline in MMSE score was seen with IAD ≥5 mmHg (OR 1.41, 95% CI = 1.03 to 1.93), and in the composite outcome with IAD ≥5 mmHg (OR 1.44, 95% CI = 1.10 to 1.89) or ≥10 mmHg (OR 1.39, 95% CI = 1.03 to 1.88). After multivariable adjustment, an IAD ≥ 5 mmHg remained associated with reductions in the composite outcome, reflecting declining cognitive performance (OR 1.46, 95% CI = 1.05 to 2.03). CONCLUSION: An IAD ≥5 mmHg is associated with cognitive decline in a representative older population. Given that systolic inter-arm differences in blood pressure are easily measured, confirmation of these findings could inform individualised treatment for the prevention of cognitive decline and dementia.
No takes yet. Share an insight, caveat, or question.
Clark et al. (2020) conducted a cohort in Cognitive decline (n=1,133). Systolic inter-arm blood pressure difference (IAD) ≥5 mmHg vs. IAD <5 mmHg was evaluated on Composite outcome representing substantial decline in MMSE, Trail Making Test A, or Trail Making Test B scores (OR 1.46, 95% CI 1.05 to 2.03, p=0.026). A systolic inter-arm blood pressure difference of ≥5 mmHg was associated with increased odds of substantial cognitive decline over a median 9-year follow-up (OR 1.46).
Synapse has enriched 10 related papers. Consider them for comparative context: